Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherCase Studies

Session 5. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments

Glen Bolton and Johannes Blümel
PDA Journal of Pharmaceutical Science and Technology August 2016, pdajpst.2016.006973; DOI: https://doi.org/10.5731/pdajpst.2016.006973
Glen Bolton
1 Amgen;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gbolton@amgen.com
Johannes Blümel
2 Paul-Ehrlich-Institut, Virology Department
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: johannes.bluemel@pei.de
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2016.006973
DOI 
https://doi.org/10.5731/pdajpst.2016.006973
PubMed 
27516482

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received June 14, 2016
  • Accepted June 23, 2016
  • Published online August 11, 2016.

Article Versions

  • You are currently viewing a previous version of this article (August 11, 2016 - 05:59).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2016, Parenteral Drug Association

Author Information

  1. Glen Bolton1,3 (gbolton{at}amgen.com) and
  2. Johannes Blümel2 (johannes.bluemel{at}pei.de)
  1. 1 Amgen;
  2. 2 Paul-Ehrlich-Institut, Virology Department
  1. ↵* Corresponding author; email: gbolton{at}amgen.com

Cited By...

  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance Applications
    Sarah Johnson, Kurt A. Brorson, Douglas D. Frey, Arun K. Dhar, David A. Cetlin
    Applied Biochemistry and Biotechnology 2017 183 1
  • The step-wise framework to design a chromatography-based hydrophobicity assay for viral particles
    Sarah A. Johnson, Alison Walsh, Matthew R. Brown, Scott C. Lute, David J. Roush, Michael S. Burnham, Kurt A. Brorson
    Journal of Chromatography B 2017 1061-1062
Next
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 2
March/April 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Session 5. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 15 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Session 5. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
Glen Bolton, Johannes Blümel
PDA Journal of Pharmaceutical Science and Technology Aug 2016, pdajpst.2016.006973; DOI: 10.5731/pdajpst.2016.006973

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Session 5. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
Glen Bolton, Johannes Blümel
PDA Journal of Pharmaceutical Science and Technology Aug 2016, pdajpst.2016.006973; DOI: 10.5731/pdajpst.2016.006973
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Phase-Incremental Decision Trees for Multi-Phase Feature Selection and Interaction in Biologics Manufacturing
  • Practical Application of Setting up an Annual Contamination Control Strategy (CCS) Assessment
  • A Risk Assessment and Risk Based Approach Review of Pre-use/Post Sterilization Integrity Testing (PUPSIT)
Show more Case Studies

Similar Articles

Keywords

  • Antibody processing
  • biotherapeutic
  • Viral clearance
  • viral filtration
  • Viral inactivation

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire